×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
EOLS – evolus, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
EOLS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/20
06:00 am
eols
Is Evolus, Inc. approaching profitability? [Yahoo! Finance]
Medium
Report
Is Evolus, Inc. approaching profitability? [Yahoo! Finance]
12/13
04:05 pm
eols
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Neutral
Report
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/22
08:11 am
eols
COSMETIC EXECUTIVE WOMEN (CEW) HONORS THE BEST IN BEAUTY [Yahoo! Finance]
Medium
Report
COSMETIC EXECUTIVE WOMEN (CEW) HONORS THE BEST IN BEAUTY [Yahoo! Finance]
11/18
02:20 pm
eols
Botox Competitor Jeuveau Launches A $49-A-Month Membership [Forbes]
Low
Report
Botox Competitor Jeuveau Launches A $49-A-Month Membership [Forbes]
11/18
11:38 am
eols
Here's Why Evolus (EOLS) Could be Great Choice for a Bottom Fisher [Yahoo! Finance]
Low
Report
Here's Why Evolus (EOLS) Could be Great Choice for a Bottom Fisher [Yahoo! Finance]
11/14
11:31 am
eols
Down -29.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Evolus (EOLS) [Yahoo! Finance]
Low
Report
Down -29.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Evolus (EOLS) [Yahoo! Finance]
11/9
09:50 am
eols
Earnings Update: Evolus, Inc. (NASDAQ:EOLS) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts [Yahoo! Finance]
Low
Report
Earnings Update: Evolus, Inc. (NASDAQ:EOLS) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts [Yahoo! Finance]
11/7
08:36 am
eols
Evolus, Inc. (NASDAQ: EOLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
High
Report
Evolus, Inc. (NASDAQ: EOLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
12/26
05:28 pm
eols
Form 4 Evolus, Inc. For: Dec 23 Filed by: MOATAZEDI DAVID
Low
Report
Form 4 Evolus, Inc. For: Dec 23 Filed by: MOATAZEDI DAVID
12/26
05:28 pm
eols
Form 4 Evolus, Inc. For: Dec 23 Filed by: Avelar Rui
Low
Report
Form 4 Evolus, Inc. For: Dec 23 Filed by: Avelar Rui
12/26
05:28 pm
eols
Form 4 Evolus, Inc. For: Dec 23 Filed by: Beaver Sandra
Low
Report
Form 4 Evolus, Inc. For: Dec 23 Filed by: Beaver Sandra
11/14
04:55 pm
eols
Form SCHEDULE 13G/A Evolus, Inc. Filed by: Nantahala Capital Management, LLC
Low
Report
Form SCHEDULE 13G/A Evolus, Inc. Filed by: Nantahala Capital Management, LLC
11/14
04:51 pm
eols
Form SC 13G/A Evolus, Inc. Filed by: PERCEPTIVE ADVISORS LLC
Low
Report
Form SC 13G/A Evolus, Inc. Filed by: PERCEPTIVE ADVISORS LLC
11/14
04:00 pm
eols
Form SC 13G/A Evolus, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
Low
Report
Form SC 13G/A Evolus, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
11/13
05:38 pm
eols
Form SC 13G/A Evolus, Inc. Filed by: Stonepine Capital Management, LLC
Low
Report
Form SC 13G/A Evolus, Inc. Filed by: Stonepine Capital Management, LLC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
6/4
Form 4/A Evolus, Inc. For: Jun 03 Filed by: Alphaeon Corp
16.7%
11/7 Evolus Announces Pricing of Public Offering of Common Stock 14.3%
7/17 Form 4 Evolus, Inc. For: Jul 15 Filed by: Parschauer Karah Herdman 11.6%
5/17 Form 424B4 Evolus, Inc. 8.0%
8/8 Juvly Aesthetics Continues Its Leadership Expansion with Appointment of a Chief People Officer 6.7%
2/25 Form 10-K Evolus, Inc. For: Dec 31 6.0%
5/21 ALPHAEON Corporation to Pay Off $88 million of Outstanding Third-Party Debt 5.4%
7/16 Form 8-K Evolus, Inc. For: Jul 15 4.8%
10/15 Evolus Inc (NASDAQ: EOLS) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 4.4%
5/31 Form 4 Evolus, Inc. For: May 31 Filed by: SILVERNAIL LAUREN P 4.2%
11/7 Evolus Announces Pricing of Public Offering of Common Stock 14.3%
7/17 Form 4 Evolus, Inc. For: Jul 15 Filed by: Parschauer Karah Herdman 11.6%
5/17 Form 424B4 Evolus, Inc. 8.0%
8/8 Juvly Aesthetics Continues Its Leadership Expansion with Appointment of a Chief People Officer 6.7%
2/25 Form 10-K Evolus, Inc. For: Dec 31 6.0%
5/21 ALPHAEON Corporation to Pay Off $88 million of Outstanding Third-Party Debt 5.4%
7/16 Form 8-K Evolus, Inc. For: Jul 15 4.8%
10/15 Evolus Inc (NASDAQ: EOLS) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 4.4%
5/31 Form 4 Evolus, Inc. For: May 31 Filed by: SILVERNAIL LAUREN P 4.2%
TOP News Decliners
5/15
ALPHAEON Corporation sells 4 million shares in Evolus Inc.
-11.2%
8/13 Evolus Inc (NASDAQ: EOLS) had its "outperform" rating re-affirmed by analysts at JMP Securities. They now have a $30.00 price target on the stock. -11.0%
3/17 Form DEF 14A Evolus, Inc. For: May 01 -10.7%
2/25 Q4/2019 12/31/2019 EPS -0.470 ZacksConsensus -0.850 ActVsEst 0.380 - Beat -8.6%
3/27 Evolus Inc (NASDAQ: EOLS) had its price target lowered by analysts at HC Wainwright from $31.00 to $16.00. They now have a "buy" rating on the stock. -8.0%
3/4 Evolus Provides Update on International Trade Commission (ITC) Case -7.7%
1/9 Form 8-K Evolus, Inc. For: Jan 09 -7.0%
1/10 Form 8-K Evolus, Inc. For: Jan 10 -6.8%
3/3 Evolus to Participate in Barclays 2020 Global Healthcare Conference -6.3%
8/12 Q2/2019 6/30/2019 EPS -1.370 ZacksConsensus -0.960 ActVsEst (0.410) - Miss -6.2%
8/13 Evolus Inc (NASDAQ: EOLS) had its "outperform" rating re-affirmed by analysts at JMP Securities. They now have a $30.00 price target on the stock. -11.0%
3/17 Form DEF 14A Evolus, Inc. For: May 01 -10.7%
2/25 Q4/2019 12/31/2019 EPS -0.470 ZacksConsensus -0.850 ActVsEst 0.380 - Beat -8.6%
3/27 Evolus Inc (NASDAQ: EOLS) had its price target lowered by analysts at HC Wainwright from $31.00 to $16.00. They now have a "buy" rating on the stock. -8.0%
3/4 Evolus Provides Update on International Trade Commission (ITC) Case -7.7%
1/9 Form 8-K Evolus, Inc. For: Jan 09 -7.0%
1/10 Form 8-K Evolus, Inc. For: Jan 10 -6.8%
3/3 Evolus to Participate in Barclays 2020 Global Healthcare Conference -6.3%
8/12 Q2/2019 6/30/2019 EPS -1.370 ZacksConsensus -0.960 ActVsEst (0.410) - Miss -6.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: